Indrayani Biotech News

Indrayani Biotech Q3FY26 Results & CFO Changes

Indrayani Biotech reported Q3FY26 results with standalone revenue of ₹520.10 lakhs and net profit of ₹8.02 lakhs. Company appointed new CFO and secured ₹5 crores credit facility.

Indrayani Biotech Gets SARFAESI Notice from Hinduja

Indrayani Biotech Limited receives SARFAESI notice from Hinduja Leyland Finance for NPA classification on term loans worth Rs. 6.46 crore as borrower and Rs. 19.12 crore as co-borrower.

Indrayani Biotech Reports Q2FY26 Results, Board Changes

Indrayani Biotech submitted Q2FY26 results showing 16.66% revenue growth in consolidated operations to ₹3,594.85 lakhs, while standalone revenue declined 37.60%. Board approved director resignation and committee reconstitution.

Indrayani Biotech Director Resigns from Board

Ms. Lakshmiprabha Kasiraman resigned as Non-Executive and Non-Independent Director of Indrayani Biotech Limited effective November 13, 2025, citing personal reasons. Her resignation also terminates her membership in various Board Committees of the company.

Indrayani Biotech Appoints Ms. Ramya Ravi as Company Secretary & Compliance Officer

Indrayani Biotech Limited appointed Ms. Ramya Ravi as Company Secretary & Compliance Officer effective September 27, 2025. The Board of Directors approved the appointment following the resignation of Mr. V Santhanakrishnan on June 12, 2025. Ms. Ravi is an Associate member of the Institute of Company Secretaries of India with membership number A53694 and has 7 years of experience in secretarial functions. She graduated from MOP Vaishnav College for Women, Chennai, and is not related to any directors of the company.